This modification mediates the upregulation of numerous genes associated with atherosclerosis, such as thrombospondin-1 (TSP-1), TGF-β, plasminogen activator inhibitor-1 (PAI-1), and nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) [66]. This evidence concerns the gene SERPINE1 and atherosclerosis.